Raises additional 16M EUR led by Dawn Biopharma, a platform controlled by KKR, with participation from existing investors.Funds will be used to further strengthen growing pipeline of first in
Copenhagen-based biotech startup Adcendo ApS has collected an additional €31M in a Series A round led by Pontifax Venture Capital and existing investors Novo
/PRNewswire/ Adcendo ApS ("Adcendo"), a biotech company focused on the development of breakthrough antibody-drug conjugates (ADCs) for the treatment of.